Navigation Links
AstraZeneca Announces Innovative New Partnership With Singapore Institutions to Develop Anti-Cancer Compounds
Date:8/14/2008

en identified for clinical screening in inoperable HCC by the institutions during 2008 and 2009. Further compounds will be made available at a rate of one per year, for the duration of the partnership, which is in place until 2012.

Professor Soo Khee Chee, NCCS Director and Assistant CEO (Research and Education) of SingHealth, said: "NCCS has a very active research programme run by high quality scientists who have produced some significant outcomes in liver cancer research. This collaboration will give our researchers and clinician scientists another opportunity to make a positive contribution that can benefit all cancer patients. Because of our wide patient base, our teams are better exposed and experienced in all types of cancer. Our large base has allowed us to carry out meaningful and effective clinical trials."

Pre-clinical activities are also included in the partnership, under the terms of which the same institutions will be given annual access to up to six novel candidate drugs for appraisal of activity in the mouse in vivo primary HCC explant model.(4)

For both clinical and pre-clinical activities, AstraZeneca retains the option to assume further development and marketing of all drugs made available as part of the partnership deal.

"This partnership with AstraZeneca is testament to the standard and quality of research in Singapore. We will work closely together to develop new anti-cancer therapies for Asian patients through access to some of AstraZeneca's clinical and pre-clinical compounds and world-class training of our researchers at MCRC," said Associate Professor Goh Boon Cher, Senior Consultant, Dept of Haematology-Oncology, National University Hospital.

Notes to Editors:

AstraZeneca

AstraZeneca is a major international healthcare business engaged in research, development, manufacturing and marketing of prescription pharmaceuticals and supplier for healthcare services. AstraZeneca is one of the world's l
'/>"/>

SOURCE AstraZeneca
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. AstraZeneca Submits an sNDA for SYMBICORT(R) for the Treatment of Asthma in Children as Young as Age Six
2. Phase III Study of Abbotts Investigational TriLipix(TM) in Combination With AstraZenecas CRESTOR(R) Meets Primary Endpoints on Key Lipids
3. AstraZeneca Submits sNDA for NEXIUM(R) I.V. for Peptic Ulcer Bleed Indication
4. Daiichi Sankyo/Eli Lillys Effient and Astrazenecas Ticagrelor May Offer Advantages in the Treatment of Post-Myocardial Infarction
5. AstraZeneca Submits sNDA for SEROQUEL XR(TM) for the Treatment of Generalized Anxiety Disorder - a First for the Atypical Antipsychotic Class of Medicines
6. Volcano Announces Participation in SATURN Clinical Trial Sponsored by AstraZeneca
7. AstraZeneca Submits an sNDA for SYMBICORT(R) for COPD Indication
8. AstraZeneca Submits sNDAs for SEROQUEL XR(TM) for the Treatment of Bipolar Mania and Bipolar Depression
9. AstraZeneca Completes Enrollment in First Phase III Study of the Investigational Drug Vandetanib (ZACTIMA)(R) in Non-Small Cell Lung Cancer
10. New Analysis of METEOR Study Demonstrate Effects of AstraZenecas CRESTOR(R) (Rosuvastatin Calcium) on Atherosclerosis in Patients With Two or More Risk Factors for Cardiovascular Disease
11. Abbott and AstraZeneca Announce Selection of Next-Generation Fenofibrate ABT-335 and CRESTOR(R) Fixed-Dose Combination
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... 1, 2015 Egalet Corporation (Nasdaq: ... company focused on discovering, developing, and commercializing innovative ...  presenting scientific data on SPRIX ® (ketorolac ... morphine product candidate, and Egalet-002, an abuse-deterrent, extended-release, ... 2015 to be held September 8 to ...
(Date:9/1/2015)...  Abbott (NYSE: ABT ) announced today positive one-year ... comparing the safety and effectiveness of Abbott,s fully dissolving ... market-leading, permanent drug eluting stent. The trial was conducted ... and enrolled 400 people with coronary artery disease, the ... be featured at a late-breaking session today at ESC ...
(Date:9/1/2015)... LAVAL, Quebec , Sept. 1, 2015 /PRNewswire/ ... and TSX: VRX) today announced that its affiliate ... under which Valeant was granted an exclusive license ... Brodalumab is an IL-17 receptor monoclonal antibody in ... psoriatic arthritis. Under the agreement, Valeant will hold ...
Breaking Medicine Technology:Egalet Announces Scientific Presentations at PainWeek 2015 Meeting 2Egalet Announces Scientific Presentations at PainWeek 2015 Meeting 3Egalet Announces Scientific Presentations at PainWeek 2015 Meeting 4Egalet Announces Scientific Presentations at PainWeek 2015 Meeting 5Egalet Announces Scientific Presentations at PainWeek 2015 Meeting 6Abbott Announces Positive Results of Its Naturally Dissolving Stent from ABSORB Japan Study 2Abbott Announces Positive Results of Its Naturally Dissolving Stent from ABSORB Japan Study 3Abbott Announces Positive Results of Its Naturally Dissolving Stent from ABSORB Japan Study 4Valeant And AstraZeneca To Partner On Brodalumab 2Valeant And AstraZeneca To Partner On Brodalumab 3Valeant And AstraZeneca To Partner On Brodalumab 4
... Pa., Nov. 19, 2010 At the ... Radiological Society of North America (RSNA), November 28 ... #822, East Building/Lakeside Center, Hall D) will unveil ... molecular Magnetic Resonance (MR) system with simultaneous data ...
... CVS Caremark,s (NYSE: CVS ) ... second in the world for Best Customer Service ... World at the organization,s Global Top Ranking Performers ... the best in the contact center industry worldwide. ...
Cached Medicine Technology:Siemens Unveils Biograph mMR Whole-Body Integrated MR-PET System Capable of Simultaneous Data Acquisition 2Siemens Unveils Biograph mMR Whole-Body Integrated MR-PET System Capable of Simultaneous Data Acquisition 3CVS Caremark Customer Care Team Awarded Silver Medal for Best Customer Service at Contact Center World's Global Top Ranking Performers Conference 2
(Date:9/1/2015)... CA (PRWEB) , ... September 01, 2015 , ... ... computing and collaboration, announces Splashtop Business for Remote Support , a solution ... support solution. Unhappy with the escalating renewal prices and inadequate customer services ...
(Date:9/1/2015)... ... September 01, 2015 , ... Plaza OBGYN ... MonaLisa Touch® , an innovative vaginal health laser procedure that prevents and ... hormone-free treatment for atrophic vaginitis, a condition that causes vaginal dryness, pelvic discomfort, ...
(Date:9/1/2015)... ... September 01, 2015 , ... The Jerry Segal Classic ... ACE Club and Green Valley Country Club in Lafayette Hill, PA. Over the past ... than $13.5 million for programs and services designed to support patients and their families ...
(Date:9/1/2015)... ... September 01, 2015 , ... ... government entities, announced today that it has hired Scott Sanderson, an experienced business ... this capacity, Sanderson will be responsible for establishing and managing new client relationships ...
(Date:9/1/2015)... New York (PRWEB) , ... September 01, 2015 , ... ... Zecurion Zlock Mac , its groundbreaking new version of endpoint DLP developed specifically for ... Zlock Mac, in which more than 100 IT and information security professionals had participated. ...
Breaking Medicine News(10 mins):Health News:Splashtop Launches Splashtop Business for Remote Support, the Simple, Reliable, and Cost-Effective Solution for MSPs and IT Professionals 2Health News:Splashtop Launches Splashtop Business for Remote Support, the Simple, Reliable, and Cost-Effective Solution for MSPs and IT Professionals 3Health News:Splashtop Launches Splashtop Business for Remote Support, the Simple, Reliable, and Cost-Effective Solution for MSPs and IT Professionals 4Health News:Houston's Plaza OB/GYN Now Offering the MonaLisa Touch® 2Health News:Houston's Plaza OB/GYN Now Offering the MonaLisa Touch® 3Health News:The 26th Jerry Segal Classic Returns to Benefit Patients of Magee Rehabilitation Hospital 2Health News:The 26th Jerry Segal Classic Returns to Benefit Patients of Magee Rehabilitation Hospital 3Health News:Former NFL Standout Scott Sanderson Joins eDiscovery Leader Discovia 2Health News:Zecurion Announces Endpoint Security for Mac 2
... coming from a family full of “lefties” tend to ... from two recent experiments answer in the affirmative. This recent ... Christman and Ruth E. Propper of the University of ... family handedness. ,Interestingly, people don’t have to be ...
... may all contribute to the decrease in bone mineral ... osteoporosis, a major cause of fractures in the elderly. Previous ... and poor clacium retention. , As part of ... Compared the bone mineral density of women in high ...
... the recipient of the world’s first fully self-contained artificial heart, ... series of setbacks. TOOLS, 59, died of complications after severe ... later, said Drs. Laman Gray Jr. and Robert Dowling, who ... // , ...
... left-handed? How about siblings? If so, you might have a better ... key lies in a part of the brain called the corpus ... with a family history of left-handedness, says study author Steven Christman. ... nerve fibers that connects the two sides of our brain and ...
... their own natural alarm clocks which can be set subconsciously ... Research conducted by scientists at the University of Lubeck in ... help them to anticipate the "stress" of getting up at ... importance of the power of thought when it comes to ...
... are known to help counter the unpleasant symptoms of a ... it is very diffcult to choose the drug. ... out an analysis of all the clinical trials on the ... with the 'gold standard' sumitriptan, a standard dose of rizatriptan ...
Cached Medicine News:Health News:The alarm clock in you 2
For temporary cardiac pacing after open heart surgery. The zig-zag portion of the heartwire is embedded into the desired area of the myocardium (epicardially)....
For temporary cardiac pacing after open heart surgery. The zig-zag portion of the heartwire is embedded into the desired area of the myocardium (epicardially)....
... Hoffmann® II Hybrid External Fixation System ... generation in hybrid fixation. It incorporates ... and is designed to offer speed ... patented Hoffmann® snap-fit technology. , ,Using ...
Versatility of the DFS Standard Fixator provides unsurpassed below-the-ring correction of angular, rotational and translational deformities. Length discrepancy can be precisely corrected in 1/4mm inc...
Medicine Products: